[Skip to Content]

Upstate Active Clinical Trials

CategoryPrincipal InvestigatorKeyword OR
ClinicalTrials.Gov ID
 

You searched for Category (Rheumatology): 9 trials found.

Click sort in the column header to sort records.
Study TitlePI
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants with Moderately to Severely Active Lupus Erythematosus. SL0043
Read more
Andras Perl, MD, PhD
A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy. 20170588
Read more
Andras Perl, MD, PhD
A Phase 2 Randomized, Double-Blind, Placebo Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus. VIB7734.P2.S1
Read more
Andras Perl, MD, PhD
A Phase 2B, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose-Ranging Study to Evaluate the Efficacy and Safety Profile of PF-06700841 in Participants with Active Systemic Lupus Erythematosus (SLE). B7931028
Read more
Andras Perl, MD, PhD
A Randomized, Double Blind, Placebo controlled, dose assessment phase II study to evaluate the safety and efficacy of CCX168 in subjects with anti-neutrophil cytoplasmic antibody (ANCAAssociated Vasculitis)
Read more
Sriram S Narsipur
A two-year, phase III randomized, double-blind, parallel-group, placebo-controlled trial to evaluate the safety, efficacy, and tolerability of 300 mg s.c. secukinumab versus placebo, in combination with SoC therapy, in patients with active lupus nephritis. CAIN457Q12301
Read more
Andras Perl, MD, PhD
AMG 592 - A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects with Active Systemic Lupus Erythematosus with Inadequate Response to Standard of Care Therapy 20200234
Read more
Andras Perl, MD, PhD
Molecular Biology and Pathology of Transaldolase
Read more
Andras Perl, MD, PhD
ROLE of HTLVS and related endogenous sequences in autoimmune diseases and human cancers
Read more
Andras Perl, MD, PhD

Search Again

Top